After Vaccines Injure Child’s Brains, Pharma Double Dips With Antidepressants

Photo by Nina A.J.

The sad, terrifying grasp that pharma has over our society is often scarier than we even understand. It all starts with people being sold on pediatric visit vaccines, poor dietary choices for those children and Monsanto’s glyphosate. And it ends with our children being put on a mainline of pharma’s finest antidepressants. They own the cycle. The only losers are our children.

The presence of major depressive disorders in children ages 6 to 18 years is growing rapidly. Children these days are exposed to a variety of toxic exposures, including not only the aforementioned but also fluoride. Neurotoxic encounters are heavy contributors to children’s depression, autism, anxiety disorders, the list really goes on. Pharma, of course, is able to monetize on this end as well offering a line of antidepressants set to “manage the symptoms. But according to a study written about in Indian Express, the antidepressants that the children are placed on fail.

Analysis of 34 trials involving 5,260 participants (average age 9 to 18 years) showed that the benefits outweighed the risks in terms of efficacy and tolerability only for fluoxetine.


However, nortriptyline was less efficacious than seven other antidepressants and placebo.

Imipramine, venlafaxine, and duloxetine had the worst profile of tolerability, leading to significantly more discontinuation than placebo. Venlafaxine was linked with an increased risk of engaging in suicidal thoughts or attempts compared with placebo and five other antidepressants.

This is how pharma works in a nutshell. They create issues via vaccines, GMO (yep, pharma is buying Monsanto), Ritalin, and even antibiotics, then they turn around and profiteer from the results. They subvert us, infect us, to a point that we look for the quick fix, such as antidepressants marketed to help with anxiety and depression. But even those must make us all worse. And in the mean time, they make pharma all the more rich.

Photo by Nina A.J.